Literature DB >> 23787781

Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice.

Wei Hu1, Yulia A Nevzorova, Ute Haas, Nives Moro, Piotr Sicinski, Yan Geng, Mariano Barbacid, Christian Trautwein, Christian Liedtke.   

Abstract

UNLABELLED: The liver has a strong regenerative capacity. After injury, quiescent hepatocytes can reenter the mitotic cell cycle to restore tissue homeostasis. This G(0) /G(1) -S cell-cycle transition of primed hepatocytes is regulated by complexes of cyclin-dependent kinase 2 (Cdk2) with E-type cyclins (CcnE1 or CcnE2). However, single genetic ablation of either E-cyclin or Cdk2 does not affect overall liver regeneration. Here, we systematically investigated the contribution of CcnE1, CcnE2, and Cdk2 for liver regeneration after partial hepatectomy (PH) by generating corresponding double- and triple-knockout (KO) mouse mutants. We demonstrate that conditional deletion of Cdk2 alone in hepatocytes resulted in accelerated induction of CcnE1, but otherwise normal initiation of S phase in vivo and in vitro. Excessive CcnE1 did not contribute to a noncanonical kinase activity, but was located at chromatin together with components of the pre-replication complex (pre-RC), such as the minichromosome maintenance (MCM) helicase. Concomitant ablation of Cdk2 and CcnE1 in hepatocytes caused a defect in pre-RC formation and further led to dramatically impaired S-phase progression by down-regulation of cyclin A2 and cell death in vitro and substantially reduced hepatocyte proliferation and liver regeneration after PH in vivo. Similarly, combined loss of CcnE1 and CcnE2, but also the Cdk2/CcnE1/CcnE2 triple KO in liver, significantly inhibited S-phase initiation and liver mass reconstitution after PH, whereas concomitant ablation of CcnE2 and Cdk2 had no effect.
CONCLUSION: In the absence of Cdk2, CcnE1 performs crucial kinase-independent functions in hepatocytes, which are capable of driving MCM loading on chromatin, cyclin A2 expression, and S-phase progression. Thus, combined inactivation of Cdk2 and CcnE1 is the minimal requirement for blocking S-phase machinery in vivo.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23787781      PMCID: PMC4236539          DOI: 10.1002/hep.26584

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation.

Authors:  Junko Odajima; Zachary P Wills; Yasmine M Ndassa; Miho Terunuma; Karla Kretschmannova; Tarek Z Deeb; Yan Geng; Sylwia Gawrzak; Isabel M Quadros; Jennifer Newman; Manjusri Das; Marie E Jecrois; Qunyan Yu; Na Li; Frederic Bienvenu; Stephen J Moss; Michael E Greenberg; Jarrod A Marto; Piotr Sicinski
Journal:  Dev Cell       Date:  2011-09-22       Impact factor: 12.270

Review 2.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

3.  Kinase-independent function of cyclin E.

Authors:  Yan Geng; Young-Mi Lee; Markus Welcker; Jherek Swanger; Agnieszka Zagozdzon; Joel D Winer; James M Roberts; Philipp Kaldis; Bruce E Clurman; Piotr Sicinski
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

Review 4.  Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

Authors:  A Satyanarayana; P Kaldis
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

5.  Cdc2-cyclin E complexes regulate the G1/S phase transition.

Authors:  Eiman Aleem; Hiroaki Kiyokawa; Philipp Kaldis
Journal:  Nat Cell Biol       Date:  2005-07-10       Impact factor: 28.824

6.  Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine.

Authors:  Kenichiro Furuyama; Yoshiya Kawaguchi; Haruhiko Akiyama; Masashi Horiguchi; Sota Kodama; Takeshi Kuhara; Shinichi Hosokawa; Ashraf Elbahrawy; Tsunemitsu Soeda; Masayuki Koizumi; Toshihiko Masui; Michiya Kawaguchi; Kyoichi Takaori; Ryuichiro Doi; Eiichiro Nishi; Ryosuke Kakinoki; Jian Min Deng; Richard R Behringer; Takashi Nakamura; Shinji Uemoto
Journal:  Nat Genet       Date:  2010-11-28       Impact factor: 38.330

7.  Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration.

Authors:  M Kasim Diril; Chandrahas Koumar Ratnacaram; V C Padmakumar; Tiehua Du; Martin Wasser; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

Review 8.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

9.  Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.

Authors:  Yulia A Nevzorova; Darjus Tschaharganeh; Nikolaus Gassler; Yan Geng; Ralf Weiskirchen; Piotr Sicinski; Christian Trautwein; Christian Liedtke
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

10.  Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo.

Authors:  Eric A Hanse; Christopher J Nelsen; Melissa M Goggin; Chelsea K Anttila; Lisa K Mullany; Cyril Berthet; Philipp Kaldis; Gretchen S Crary; Ryoko Kuriyama; Jeffrey H Albrecht
Journal:  Cell Cycle       Date:  2009-09-08       Impact factor: 4.534

View more
  16 in total

1.  MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells.

Authors:  Ma Isabel Zubillaga-Guerrero; Luz Del Carmen Alarcón-Romero; Berenice Illades-Aguiar; Eugenia Flores-Alfaro; Víctor Hugo Bermúdez-Morales; Jessica Deas; Oscar Peralta-Zaragoza
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.

Authors:  Roland Sonntag; Nives Giebeler; Yulia A Nevzorova; Jörg-Martin Bangen; Dirk Fahrenkamp; Daniela Lambertz; Ute Haas; Wei Hu; Nikolaus Gassler; Francisco Javier Cubero; Gerhard Müller-Newen; Ali T Abdallah; Ralf Weiskirchen; Fabio Ticconi; Ivan G Costa; Mariano Barbacid; Christian Trautwein; Christian Liedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

3.  Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.

Authors:  Yan-Dong Wang; Yong-Jing Su; Jian-Ying Li; Xiang-Chao Yao; Guang-Jiang Liang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 4.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

5.  The role of ubiquitin signaling pathway on liver regeneration in rats.

Authors:  Ayse Ozmen Yaylaci; Mediha Canbek
Journal:  Mol Cell Biochem       Date:  2022-06-24       Impact factor: 3.396

6.  β2-adrenergic receptor promotes liver regeneration partially through crosstalk with c-met.

Authors:  Xiang Tao; Can Chen; Yingxiang Chen; Luoying Zhang; Jiong Hu; Hongjun Yu; Minglu Liang; Qin Fu; Kai Huang
Journal:  Cell Death Dis       Date:  2022-06-27       Impact factor: 9.685

7.  Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.

Authors:  Haksier Ehedego; Antje Mohs; Bettina Jansen; Kanishka Hiththetiya; Piotr Sicinski; Christian Liedtke; Christian Trautwein
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

Review 8.  Cyclin E in normal physiology and disease states.

Authors:  Chen Chu; Yan Geng; Yu Zhou; Piotr Sicinski
Journal:  Trends Cell Biol       Date:  2021-05-27       Impact factor: 21.167

9.  Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo.

Authors:  R Sonntag; N Gassler; J-M Bangen; C Trautwein; C Liedtke
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

10.  The E2F2 transcription factor sustains hepatic glycerophospholipid homeostasis in mice.

Authors:  Eduardo N Maldonado; Igotz Delgado; Natalia E Furland; Xabier Buqué; Ainhoa Iglesias; Marta I Aveldaño; Ana Zubiaga; Olatz Fresnedo; Begoña Ochoa
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.